CORDIS
EU research results

CORDIS

English EN

Springboard for excellence in advanced development of antibacterials

Project information

Grant agreement ID: 951883

Status

Grant agreement signed

  • Start date

    1 September 2020

  • End date

    31 August 2023

Funded under:

H2020-EU.4.b.

  • Overall budget:

    € 899 962,50

  • EU contribution

    € 899 962,50

Coordinated by:

LATVIJAS ORGANISKAS SINTEZES INSTITUTS

Latvia

Objective

The main goal of SPRINGBOARD project is to strengthen research potential of the Latvian Institute of Organic Synthesis (LIOS) through establishing long-lasting and sustainable collaboration network with the leading European research institutions – University of Antwerp, University of Copenhagen, University of Florence and University of Helsinki – in the area of advanced discovery and design of novel antibacterial drugs. An increased competence of LIOS staff (especially early stage researchers) on identification of new enzymatic targets, application of natural products and their synthetic analogues, biopharmaceuticals, antisense and peptide antibiotics as antibacterials, as well as experience on biofilm formation and quorum sensing molecules as targets for new antibacterial therapies will be achieved as a result.
The implementation of SPRINGBOARD will ensure the establishment of platform of excellence in this area through:
•exchange of the best practice via staff exchange and expert visits;
•increase capacity building of early stage researchers;
•improvement of research management and administration skills;
•organization of joint events;
•building capacity for participation in competitive joint proposals of projects for Horizon Europe and other relevant programmes;
•dissemination, communication and outreach activities.
This collaboration will ensure:
•full exploitation of research and innovation capacity of LIOS;
•rise of LIOS staff research profiles focusing on early stage researchers;
•increase in LIOS visibility and integration in ERA;
•contribution to actual socio-economic challenge in connection to widespread infectious diseases;
•public awareness on the importance of development of new antibacterial drugs.
SPRINGBOARD will contribute to the Responsible Research and Innovation approach that will support creation and interdisciplinary collaboration as well as knowledge exchange to improve public health and quality of life.

Coordinator

LATVIJAS ORGANISKAS SINTEZES INSTITUTS

Address

Aizkraukles 21
1006 Riga

Latvia

Activity type

Research Organisations

EU Contribution

€ 466 250

Participants (4)

UNIVERSITA DEGLI STUDI DI FIRENZE

Italy

EU Contribution

€ 95 125

HELSINGIN YLIOPISTO

Finland

EU Contribution

€ 101 775

KOBENHAVNS UNIVERSITET

Denmark

EU Contribution

€ 116 562,50

UNIVERSITEIT ANTWERPEN

Belgium

EU Contribution

€ 120 250

Project information

Grant agreement ID: 951883

Status

Grant agreement signed

  • Start date

    1 September 2020

  • End date

    31 August 2023

Funded under:

H2020-EU.4.b.

  • Overall budget:

    € 899 962,50

  • EU contribution

    € 899 962,50

Coordinated by:

LATVIJAS ORGANISKAS SINTEZES INSTITUTS

Latvia